However, the clear drawback of cultivating cells as myoblasts or bone-marrow-derived MSCs is the limitation of their potential use in patients with acute myocardial infarction. In these patients ...

Patients with these conditions commonly attend primary care and are repeatedly hospitalised with acute coronary syndromes ... Non-invasive functional testing includes myocardial perfusion scintigraphy ...

SCS aligns with terminology for acute coronary syndromes, and helps to standardise the hierarchy of IHD endotypes, including ischaemia with no obstructive coronary artery disease (INOCA)3 and ...

IV thrombolysis given within 4.5 hours of acute pontine infarction may significantly reduce neurological deterioration vs ...

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

Researchers continue to advance the science to determine best treatments for stroke. Based on an international study of 530 patients, researchers discovered that while the clot retrieval procedure ...

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

and colleagues examined the potential of a new GFAP point-of-care test for rapidly distinguishing ICH from IS and stroke ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

People with brain bleeds had nearly 7 times higher blood levels of a specific brain protein, called glial fibrillary acidic protein (GFAP), than those who had strokes caused by clots in a study ...